9.43
-0.05
(-0.50%)
As of 9:39:19 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-32,480.00
-27,927.00
-78,908.00
-108,235.00
-90,694.00
Investing Cash Flow
-146.00
-429.00
62,717.00
70,803.00
-78,209.00
Financing Cash Flow
25,765.00
8,506.00
-7,942.00
42,554.00
160,628.00
End Cash Position
49,202.00
50,895.00
70,745.00
94,878.00
89,756.00
Interest Paid Supplemental Data
4,602.00
4,620.00
5,958.00
6,837.00
7,528.00
Capital Expenditure
-146.00
-610.00
-313.00
-5,539.00
-1,942.00
Issuance of Capital Stock
25,825.00
20,501.00
31,796.00
41,232.00
158,557.00
Issuance of Debt
--
--
--
77,782.00
--
Repayment of Debt
-18.00
-10,000.00
-40,039.00
-78,045.00
-32.00
Free Cash Flow
-32,626.00
-28,537.00
-79,221.00
-113,774.00
-92,636.00
12/31/2020 - 7/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CTMX CytomX Therapeutics, Inc.
0.8989
+2.76%
SLDB Solid Biosciences Inc.
3.3500
+0.91%
ALDX Aldeyra Therapeutics, Inc.
5.52
+2.23%
CDTX Cidara Therapeutics, Inc.
18.00
-0.55%
ASMB Assembly Biosciences, Inc.
14.25
-1.25%
KURA Kura Oncology, Inc.
8.08
+0.62%
ATNF 180 Life Sciences Corp.
1.4700
+2.08%
PALI Palisade Bio, Inc.
1.4073
-1.59%
IKT Inhibikase Therapeutics, Inc.
2.0700
+7.81%
AFMD Affimed N.V.
1.0000
+2.10%